Centerpoint Advisors’s Northrop Grumman NOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8K Hold
16
﹤0.01% 348
2026
Q1
$11K Hold
16
﹤0.01% 311
2025
Q4
$9K Sell
16
-2
-11% -$1.16K ﹤0.01% 328
2025
Q3
$11K Buy
18
+16
+800% +$9.07K ﹤0.01% 326
2025
Q2
$1K Buy
+2
New +$983 ﹤0.01% 371
2023
Q4
Sell
-3
Closed -$1K 544
2023
Q3
$1K Hold
3
﹤0.01% 520
2023
Q2
$1K Sell
3
-75
-96% -$34K ﹤0.01% 518
2023
Q1
$36K Buy
78
+1
+1% +$464 0.02% 187
2022
Q4
$42K Buy
77
+2
+3% +$1.04K 0.02% 152
2022
Q3
$35K Hold
75
0.02% 152
2022
Q2
$36K Hold
75
0.02% 159
2022
Q1
$34K Hold
75
0.02% 171
2021
Q4
$29K Hold
75
0.01% 158
2021
Q3
$27K Hold
75
0.01% 154
2021
Q2
$27K Buy
+75
New +$27K 0.01% 158
2020
Q1
Sell
-208
Closed -$72K 270
2019
Q4
$72K Hold
208
0.05% 81
2019
Q3
$78K Hold
208
0.06% 78
2019
Q2
$67K Hold
208
0.05% 83
2019
Q1
$56K Hold
208
0.05% 96
2018
Q4
$51K Hold
208
0.05% 97
2018
Q3
$66K Hold
208
0.05% 83
2018
Q2
$64K Hold
208
0.05% 87
2018
Q1
$73K Buy
+208
New +$69.7K 0.06% 78

Other funds holding NOC

Centerpoint Advisors's NOC Position: Q2 2026 in Review

Centerpoint Advisors held its Northrop Grumman (NOC) position steady in Q2 2026 at 16 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #348.

Centerpoint Advisors first reported a position in NOC in Q1 2018 and has held it in 23 quarters since. The position peaked at $78K in Q3 2019. 1,812 funds tracked by Wall St. Rank hold NOC as of Q2 2026.

  • Centerpoint Advisors held 16 shares of Northrop Grumman worth $8K as of Q2 2026.
  • Centerpoint Advisors left its Northrop Grumman share count unchanged in Q2 2026.
  • Northrop Grumman made up ﹤0.01% of Centerpoint Advisors's portfolio in Q2 2026, its #348 holding.
  • Centerpoint Advisors first reported a position in Northrop Grumman in Q1 2018 and has held it in 23 quarters since.
  • Centerpoint Advisors's Northrop Grumman position peaked at $78K in Q3 2019.
  • 1,812 funds tracked by Wall St. Rank held Northrop Grumman as of Q2 2026.

Based on Centerpoint Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.